Too many #fakepatents granted by #USPTO for the sole purpose of fee collection; taking those to #PTAB and #CAFC is very expensive, so it doesn't solve the problem as much as dissolving this current, greed-driven system https://www.businesswire.com/news/home/20211109006077/en/Ocular-Therapeutix™-Announces-Success-in-Patent-Appeal-Brought-by-Mati-Therapeutics-Inc.